Effect of Warm Bupivacaine on Subtenon Block.
Key facts
- Who runs it
- Mansoura University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 120 people enrolled
- Started
- 1 Oct 2025
- Ended
- 20 Jan 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- room temperature Bupivacaine
- warm Bupivacaine
- Record updated
- 27 January 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- American Society of Anesthesiology (ASA) I, II or III patients
- Patients scheduled for elective unilateral cataract surgery
Who cannot take part
- Altered mental status or un-cooperative patients or psychiatric disorder
- History of anesthetic drug allergy
- Pre-existing progressive demyelinating neurologic pathology or neuromuscular disorders
- Any contraindications to block (as bleeding or coagulation diathesis)
- Patient refusal to participate in the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Sub-Tenon's anesthesia is now widely regarded as a preferred local anesthetic method for cataract surgery. Various techniques have been explored to prolong the duration, shorten onset time and improve the efficacy of local anesthetic nerve blocks with varying degrees of success. Warming local anesthetic may speed up its onset and prolong its effect by lowering its pKa.The aim of this study is to evaluate the effect of warming bupivacaine on the characteristics of a sub-Tenon's block in patients undergoing cataract surgery. It is hypothesized that warming bupivacaine 0.5% to 37°C will improve the characteristics of sub-Tenon's block. It will prolong the duration of sensory and motor block and accelerate the time onset time of sensory and motor block.
The 2 groups in the trial
- Operating room temperature bupivacaineTreatment being tested
patients will receive local anesthetic (5ml containing 5mg bupivacaine) that will be on a sterile shelf in the operating room at 23°C. The empty syringes and needles will be also on the same shelf before their use.
Treatment: room temperature Bupivacaine
- Warm bupivacaineTreatment being tested
patients will receive local anesthetic (5ml containing 5mg bupivacaine) warmed to 37◦C for 20 minutes. The empty syringes and needles, in their packaging, will be held at the same temperature for at least 2 hours before initiating the block.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Influence Of Bupivacaine Temperature On Subtenon Block Characteristics: A Prospective, Randomized, Controlled Trial
- Record updated
- 27 January 2026